​

Omega Therapeutics (OMGA) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChart

OMGA Stock Forecast

Omega Therapeutics (OMGA) stock forecast, based on 7 Wall Street analysts, predicts a 12-month average price target of $9.00, with a high of $11.00 and a low of $7.00. This represents a 6328.57% increase from the last price of $0.14.

- $3 $6 $9 $12 $15 High: $11 Avg: $9 Low: $7 Last Closed Price: $0.14

OMGA Stock Rating

Omega Therapeutics stock's rating consensus is Buy, based on 7 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 6 Buy (85.71%), 1 Hold (14.29%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 7 0 1 6 Strong Sell Sell Hold Buy Strong Buy

OMGA Price Target Upside V Benchmarks

TypeNameUpside
StockOmega Therapeutics6328.57%
SectorHealthcare Stocks 18.80%
IndustryBiotech Stocks 54.28%

Price Target Trends

1M3M12M
# Anlaysts---
Avg Price Target---
Last Closing Price$0.14$0.14$0.14
Upside/Downside---
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Mar, 2512---3
Feb, 25241--7
Jan, 25241--7
Dec, 24341--8
Nov, 24351--9
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Apr 03, 2024Edward TenthoffPiper Sandler$9.00$3.01199.00%6328.57%
Apr 01, 2024Keay NakaeLoop Capital Markets$7.00$3.6591.78%4900.00%
Dec 08, 2022H.C. Wainwright$11.00$6.3074.60%7757.14%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Nov 15, 2024Piper SandlerOverweightOverweighthold
Aug 15, 2024WedbushBuyBuyhold
Jun 18, 2024Piper SandlerUnderperformUnderperformhold
Jun 18, 2024Raymond JamesOutperforminitialise
May 07, 2024Chardan CapitalUnderperformUnderperformhold
Apr 03, 2024Piper SandlerOverweightOverweighthold
Apr 01, 2024Chardan CapitalBuyBuyhold

Financial Forecast

EPS Forecast

Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-2.14$-1.80-----
Avg Forecast$-2.12$-1.88$-1.17$-0.79$-0.44$-0.28$-0.12
High Forecast$-1.47$-1.84$-1.08$-0.37$-0.36$-0.20$-0.04
Low Forecast$-3.09$-2.00$-1.24$-1.12$-0.52$-0.36$-0.22
Surprise %0.94%-4.26%-----

Revenue Forecast

$0 $6M $12M $18M $24M $30M Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$2.07M$3.09M-----
Avg Forecast$1.58M$2.55M$8.53M$4.31M$6.62M$16.61M$10.49M
High Forecast$2.14M$3.09M$9.45M$7.11M$10.92M$27.43M$17.32M
Low Forecast$1.21M$2.09M$7.60M$2.15M$3.30M$8.29M$5.23M
Surprise %30.91%21.24%-----

Net Income Forecast

$-200M $-160M $-120M $-80M $-40M $0 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-102.64M$-97.43M-----
Avg Forecast$-114.72M$-103.72M$-62.66M$-40.10M$-23.76M$-15.12M$-6.48M
High Forecast$-79.58M$-99.26M$-58.16M$-19.92M$-19.36M$-11.00M$-2.26M
Low Forecast$-166.88M$-108.19M$-67.15M$-60.28M$-28.17M$-19.25M$-11.97M
Surprise %-10.53%-6.07%-----

OMGA Forecast FAQ

Is Omega Therapeutics stock a buy?

Omega Therapeutics stock has a consensus rating of Buy, based on 7 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 6 Buy, 1 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Omega Therapeutics is a favorable investment for most analysts.

What is Omega Therapeutics's price target?

Omega Therapeutics's price target, set by 7 Wall Street analysts, averages $9 over the next 12 months. The price target range spans from $7 at the low end to $11 at the high end, suggesting a potential 6328.57% change from the previous closing price of $0.14.

How does Omega Therapeutics stock forecast compare to its benchmarks?

Omega Therapeutics's stock forecast shows a 6328.57% upside, outperforming the average forecast for the healthcare stocks sector (18.80%) and outperforming the biotech stocks industry (54.28%).

What is the breakdown of analyst ratings for Omega Therapeutics over the past three months?

  • March 2025: 33.33% Strong Buy, 66.67% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • February 2025: 28.57% Strong Buy, 57.14% Buy, 14.29% Hold, 0% Sell, 0% Strong Sell.
  • January 2025: 28.57% Strong Buy, 57.14% Buy, 14.29% Hold, 0% Sell, 0% Strong Sell.

What is Omega Therapeutics’s EPS forecast?

Omega Therapeutics's average annual EPS forecast for its fiscal year ending in December 2024 is $-1.17, marking a -35.00% decrease from the reported $-1.8 in 2023. Estimates for the following years are $-0.79 in 2025, $-0.44 in 2026, $-0.28 in 2027, and $-0.12 in 2028.

What is Omega Therapeutics’s revenue forecast?

Omega Therapeutics's average annual revenue forecast for its fiscal year ending in December 2024 is $8.53M, reflecting a 175.69% increase from the reported $3.09M in 2023. The forecast for 2025 is $4.31M, followed by $6.62M for 2026, $16.61M for 2027, and $10.49M for 2028.

What is Omega Therapeutics’s net income forecast?

Omega Therapeutics's net income forecast for the fiscal year ending in December 2024 stands at $-62.658M, representing a -35.69% decrease from the reported $-97.428M in 2023. Projections indicate $-40.1M in 2025, $-23.765M in 2026, $-15.123M in 2027, and $-6.481M in 2028.